Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1/2 1

Status

Unknown 3Recruiting 1Completed 1

Sponsor Class

OTHER 533INDUSTRY 52OTHER_GOV 25NIH 11UNKNOWN 5

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 5

Conditions

Breast Neoplasms 42Esophageal Neoplasms 24Stomach Neoplasms 21Rectal Neoplasms 15Carcinoma, Non-Small-Cell Lung 14Colorectal Neoplasms 12Neoplasms 10Lung Neoplasms 10Brain Neoplasms 10Triple Negative Breast Neoplasms 9Small Cell Lung Carcinoma 8Squamous Cell Carcinoma of Head and Neck 7Neoplasm Metastasis 6Esophageal Squamous Cell Carcinoma 6Nasopharyngeal Carcinoma 5Lymphoma, Large B-Cell, Diffuse 5Carcinoma, Hepatocellular 5Recurrence 4Radiation Injuries 4Melanoma 4Lymphoma, Extranodal NK-T-Cell 4Head and Neck Neoplasms 4Uterine Cervical Neoplasms 3Meningeal Carcinomatosis 3Lymphoma 3Leukemia, Myeloid, Acute 3Hormone Receptor Positive Advanced Breast Cancer 3HER2-positive Breast Cancer 3Colonic Neoplasms 3Vomiting 2

Interventions

Cisplatin 3nimotuzumab 1anlotinib 1Radiotherapy, Intensity-Modulated 1Gemcitabine 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
UNKNOWN × Nasopharyngeal Carcinoma × Clear all
NCT05145660 2022-09-27

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

ChineseAMS

Phase 3 Recruiting
414 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT01817023 2021-01-29

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

ChineseAMS

Phase 3 Unknown
590 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03915132 2021-01-29

Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma

ChineseAMS

Phase 2 Unknown
47 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT01187238 2020-07-16

The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

ChineseAMS

Phase 2 Completed
84 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03639467 2018-09-18

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

ChineseAMS

Phase 1/2 Unknown
40 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡